SUBSCRIBE
SUBSCRIBE

IPO

Deals
BoneSupport Preps for $62 Million IPO
June 15, 2017
 · 
1 min read
Deals
The First Regulation A+ IPO To The NYSE - Here’s How They Made Their Success
June 15, 2017
 · 
1 min read
Deals
Aileron Therapeutics Files For $69 Million IPO As New Offerings Heat Up
June 6, 2017
 · 
1 min read
Deals
Cambridge’s Takeda-Backed Mersana Files for $75 Million IPO
June 2, 2017
 · 
1 min read
Deals
Booming Wuxi Biologics Gears Up For $513 Million IPO
May 24, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO
May 17, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO
May 16, 2017
 · 
4 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
Cancer Biotech G1 Therapeutics Files for $115 Million IPO
April 18, 2017
 · 
2 min read
Business
Biopharma IPOs Sluggish In Q1. Will That Continue?
April 14, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
It’s Official: Ovid CEO Just Filed for $86 Million IPO
April 12, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Press Releases
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 6, 2026
 · 
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
 · 
3 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
 · 
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
 · 
4 min read
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
 · 
12 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
 · 
5 min read
Press Releases
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
 · 
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
 · 
4 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
 · 
3 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
 · 
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
 · 
4 min read
Press Releases
Lumexa Imaging Announces Launch of Initial Public Offering
December 2, 2025
 · 
2 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
November 19, 2025
 · 
1 min read
Press Releases
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
November 18, 2025
 · 
5 min read
Press Releases
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares
November 11, 2025
 · 
1 min read
Press Releases
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 10, 2025
 · 
2 min read
Load More